Overview
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia
Status:
Completed
Completed
Trial end date:
2017-04-25
2017-04-25
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Criteria
Inclusion Criteria:- Male of female of at least 19 years old
- Patient with functional dyspepsia met the ROME III criteria
Exclusion Criteria:
- Patients with previous gastrointestinal surgery
- Patients with history of gastrointestinal bleeding, mechanical obstruction,
perforation
- Patients with history of gastrointestinal cancer